doi:10.1056/NEJMoa2511774 3
It is Retatrutide, Lilly's injectable "Triple Agonist." It hits three receptors: GLP-1, GIP, and Glucagon
First, it is a pentadecapeptide, meaning it contains exactly 15 amino acids, which places it in the medium-length peptide range (longer than tripeptides like GHK-Cu, shorter than full protein fragments like AOD-9604)
Melanotic macules are benign and no malignant transformation to a melanoma has been recorded A macule indicates the presence of a flat, distinct, discolored area of skin less than 1 cm wide
Lactate is undoubtedly involved in energy metabolism
These subtle details matter greatly in digital health - where too much complexity often erodes engagement